Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Freudenstadt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on hormone receptor-positive HER2-negative breast cancer, exploring combination therapies with endocrine treatment approaches.
Research aims to evaluate treatment effectiveness and patient outcomes through systematic monitoring and assessment.
Groundbreaking research investigating advanced biliary tract cancers through combination therapy approaches using immunotherapy and chemotherapy.
The research focuses on evaluating novel treatment combinations to improve patient outcomes in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
